Leonardo Proaño-Bernal

Leonardo Proaño-Bernal

Auto-generated profile, based on publicly available information

Leonardo Proaño-Bernal

Department of Nuclear Cardiology, National Institute of Cardiology Ignacio Chavez, Mexico City, Mexico

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2022 in Antioxidants
Verified
Journal Article
Open access
PDF file
JBJorge Luis Bermudez-Gonzalez
Jorge Luis Bermudez-Gonzalez
DQDenya Sánchez Quintero
Denya Sánchez Quintero
LPLeonardo Proaño-Bernal
Leonardo Proaño-Bernal
RSRafael Santana
Rafael Santana
MJMarco Antonio Jimenez-Chavarria
Marco Antonio Jimenez-Chavarria
EAErick Alexanderson-Rosas
Erick Alexanderson-Rosas
Ischemia-reperfusion injury is a common problem in the age of interventional cardiology; it is primarily mediated by oxidative stress and reactive agents. Melatonin has antioxidative properties that make its use promising for treating ischemia-reperfusion injury. Multiple experimental studies in murine and porcine models have been performed with good results. Clinical trials have also been conducted but given their heterogeneity, no conclusive results can be made. Melatonin pharmacokinetic properties are not ideal; therefore, many analogs have been proposed with improved characteristics, and some studies have evaluated their efficacy in animal models, but clinical trials are needed to recommend their use. In this review, we expose the results of the most impactful studies regarding melatonin use in ischemia-reperfusion injury.

28 March 2024 in Radiology Case Reports
Verified
Journal Article
Open access
SLSantiago Luna-Alcala
Santiago Luna-Alcala
MGMauricio Garcia-Cardenas
Mauricio Garcia-Cardenas
EGEnrique C. Guerra
Enrique C. Guerra
PMPavel Martinez-Dominguez
Pavel Martinez-Dominguez
ACAldo Cabello-Ganem
Aldo Cabello-Ganem
NZNilda Espinola Zavaleta
Nilda Espinola Zavaleta
Arrhythmogenic cardiomyopathy is a biventricular disease in which the effect on the left ventricle can be either equivalent to or more severe than that on the right ventricle. It is a rare disease due to its low reported prevalence and typically becomes clinically evident during the second to fourth decade of life. It represents 4% of sudden cardiac death cases referred for autopsy and 10% of cases of unexplained cardiac arrest. We present a challenging case report of a 68-year-old man who arrived at the emergency room with chest discomfort, palpitations, and light-headedness before a syncopal episode with urinary incontinence. During monitoring, ventricular tachycardia was detected and was treated with cardioversion. However, a follow-up electrocardiogram revealed low QRS voltages in limb leads and T-wave inversion in the left precordial leads. The patient underwent a transthoracic echocardiogram and a gadolinium-based magnetic resonance imaging study to evaluate the possibility of acute decompensated heart failure. Both imaging studies revealed low ejection fraction and systolic dysfunction in both right and left ventricles. Furthermore, in the late gadolinium enhancement study, extensive left ventricular subepicardial enhancement with septal predominance in a ring pattern and an irregular morphology of the right ventricular free wall were observed. A diagnosis of biventricular arrhythmogenic cardiomyopathy was established based on the 2020 Padua Criteria. Although there is not a recognized classification within these criteria to establish its subtype, in our case there was a left ventricular predominance due to the presence of additional left ventricular categories.

17 November 2023 in Clinical Case Reports
Verified
Journal Article
Open access
RVRaúl Velázquez‐Castañeda
Raúl Velázquez‐Castañeda
IPIlana De La Puente‐Tawil
Ilana De La Puente‐Tawil
SMSofía Molina‐Castillo
Sofía Molina‐Castillo
LPLeonardo Proaño‐Bernal
Leonardo Proaño‐Bernal
MRMariell Alejandra Rodríguez‐Salazar
Mariell Alejandra Rodríguez‐Salazar
VAVincenzo Arenas‐Fabbri
Vincenzo Arenas‐Fabbri
Key Clinical Message: Coronary artery fistula is a rare abnormal connection between the heart arteries. Patients may remain asymptomatic until adulthood, potentially experiencing life‐threatening complications. Adequate monitoring and therapeutic management are essential.

1 January 2021 in Clinical Research and Trials
Verified
Journal Article
Open access
JSJuan Ignacio Straface
Juan Ignacio Straface
MGMiguel Angel Gonzalez-Hernandez
Miguel Angel Gonzalez-Hernandez
MGMauricio Garcia-Cardenas
Mauricio Garcia-Cardenas
LPLeonardo Proano-Bernal
Leonardo Proano-Bernal
RSRafael Santana-Apreza
Rafael Santana-Apreza
EAErick Alexanderson-Rosas
Erick Alexanderson-Rosas
OA Text is an independent open-access scientific publisher showcases innovative research and ideas aimed at improving health by linking research and practice to the benefit of society.

31 July 2023 in Echocardiography
Verified
Journal Article
Closed access
AMAna Danissa Michel‐Vázquez
Ana Danissa Michel‐Vázquez
SLSantiago Luna‐Alcala
Santiago Luna‐Alcala
EGEnrique C. Guerra
Enrique C. Guerra
LPLeonardo Proaño‐Bernal
Leonardo Proaño‐Bernal
ACAldo Cabello‐Ganem
Aldo Cabello‐Ganem
NZNilda Espinola Zavaleta
Nilda Espinola Zavaleta